LWBA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Mesoblast Ltd

Watchlist Manager

Watchlist

Price: 3.58 EUR 0.56% Market Closed

Market Cap: €582.6m

M	Mesoblast Ltd F:LWBA	AU
G	Geron Corp SWB:GON	US
P	Prudential Financial Inc SWB:PLL	US
F	Flowserve Corp F:FWV	US
G	General Dynamics Corp XHAM:GDX	US
A	Amata Corporation PCL SET:AMATA	TH
E	Epizyme Inc F:EPE	US
B	Bristol-Myers Squibb Co XHAM:BRM	US

Profitability Summary

Mesoblast Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

58%

Negative 3Y Average Gross Margin

-50%

Gross Margin is Increasing

-270% > 58%

Negative Operating Margin

-112%

Negative 3Y Average Operating Margin

-786%

Operating Margin is Increasing

-836% > -112%

Negative Net Margin

-144%

Negative 3Y Average Net Margin

-1.020%

Net Margin is Increasing

-1.092% > -144%

Negative Free Cash Flow Margin

-93%

Negative 3Y Average Free Cash Flow Margin

-601%

Free Cash Flow Margin is Increasing

-847% > -93%

Negative ROE

-18%

Negative 3Y Average ROE

Negative 3Y Average ROIC